China Shineway Pharmaceutical Group Salute del bilancio
Salute finanziaria criteri di controllo 5/6
China Shineway Pharmaceutical Group ha un patrimonio netto totale di CN¥7.3B e un debito totale di CN¥330.0M, che porta il suo rapporto debito/patrimonio netto a 4.5%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥9.9B e CN¥2.5B. L'EBIT di China Shineway Pharmaceutical Group è CN¥944.7M rendendo il suo rapporto di copertura degli interessi -5.7. Ha liquidità e investimenti a breve termine pari a CN¥6.2B.
Informazioni chiave
4.5%
Rapporto debito/patrimonio netto
CN¥330.00m
Debito
| Indice di copertura degli interessi | -5.7x |
| Contanti | CN¥6.23b |
| Patrimonio netto | CN¥7.34b |
| Totale passività | CN¥2.55b |
| Totale attività | CN¥9.88b |
Aggiornamenti recenti sulla salute finanziaria
Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?
May 13
China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly
Sep 28China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Apr 07We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease
Dec 10
Recent updates
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%
Oct 18If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity
Jun 03Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?
May 13China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461
Apr 26Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?
Apr 17China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461
Mar 31China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings
Mar 14Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?
Jan 29China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly
Sep 28China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118
Sep 01We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Aug 03Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?
May 30We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Mar 07China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125
Sep 01China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 31China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Apr 07China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.
Mar 11Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?
Feb 18Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?
Jan 31Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?
Jan 13What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?
Dec 25We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease
Dec 10Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years
Nov 25Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( CN¥8.5B ) di 2877 superano le sue passività a breve termine ( CN¥2.4B ).
Passività a lungo termine: Le attività a breve termine di 2877 ( CN¥8.5B ) superano le sue passività a lungo termine ( CN¥113.0M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 2877 ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di 2877 è aumentato da 0% a 4.5% negli ultimi 5 anni.
Copertura del debito: Il debito di 2877 è ben coperto dal flusso di cassa operativo ( 356.2% ).
Copertura degli interessi: 2877 matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.